Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Switzerland

Marie Skłodowska-Curie Action · Running

REHEAR REHEAR: Reverse Engineered Hearing Evaluation for Auditory-neuropathy Recognition

Coordinator
Universitat Zurich, Switzerland
Runs
1 May 2026 to 30 April 2028
Status
Running
EU funding
€308k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101275781

What the project is doing

In the project's own words, from its summary on CORDIS.

Auditory Neuropathy Spectrum Disorder (ANSD) affects up to 10% of individuals with hearing loss. Unlike typical cases, people with ANSD detect sounds but struggle with speech understanding due to disrupted auditory nerve timing. Current tests cannot identify specific neural mechanisms, making treatment unpredictable. ANSD patients often cycle through multiple failed treatments - hearing aids provide minimal benefit, and cochlear implant outcomes vary dramatically from excellent to poor.

This creates prolonged periods of communication difficulty during critical developmental years for children and significant quality-of-life impacts for adults. Cochlear implants provide unique access to neural responses via electrical recordings (ECAPs), enabling mechanism-specific diagnosis. This project develops the first computational-to-clinical bridge for ANSD using reverse engineering: instead of measuring neural dysfunction directly, we embed ANSD-specific disruption patterns into speech materials, creating diagnostic tests that make neural problems ""hearable."" Two complementary frameworks—mathematical optimization and AI-based learning—convert neural dysfunction patterns into targeted speech tests while preserving disorder-specific diagnostic signatures.

The methodology includes three work packages: developing computational frameworks, validating through behavioral experiments with normal-hearing listeners (n=40) and cochlear implant users (n=12-15 each) alongside neural validation, and optimizing clinical protocols. Based at University Hospital Zurich's Deep Hearing Lab under Prof. Goehring's supervision, this fellowship advances expertise in computational neuroscience and clinical translation, delivering the first validated framework for ANSD subtype diagnosis and precision hearing care for thousands of patients annually across Europe, with potential healthcare savings through reduced diagnostic workup times and improved treatment matching.""

Topics

Who is involved

OrganisationCityCountryRole
Universitat ZurichZurichSwitzerlandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI